Detalhe da pesquisa
1.
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy.
Breast Cancer Res Treat
; 199(2): 231-241, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36947277
2.
Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol
; 53(3): 203-211, 2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36484305
3.
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
Lancet Oncol
; 23(5): 636-649, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405087
4.
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
Cancer Sci
; 113(9): 3169-3179, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35754298
5.
Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol
; 52(6): 545-553, 2022 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296894
6.
Identification and characterization of a novel class of self-sufficient cytochrome P450 hydroxylase involved in cyclohexanecarboxylate degradation in Paraburkholderia terrae strain KU-64.
Biosci Biotechnol Biochem
; 86(2): 199-208, 2022 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965585
7.
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer Patients.
Acta Med Okayama
; 76(6): 661-671, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549768
8.
HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells.
Breast Cancer Res Treat
; 186(1): 37-51, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452951
9.
Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).
Invest New Drugs
; 39(1): 217-225, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833136
10.
Cloning, expression, and characterization of Baeyer-Villiger monooxygenases from eukaryotic Exophiala jeanselmei strain KUFI-6N.
Biosci Biotechnol Biochem
; 85(7): 1675-1685, 2021 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930112
11.
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.
Breast Cancer Res Treat
; 173(1): 123-133, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30242578
12.
Prediction of pathological response to neoadjuvant chemotherapy in breast cancer patients by imaging.
J Surg Res
; 225: 175-180, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29605029
13.
Survival outcomes of neoadjuvant chemotherapy with zoledronic acid for HER2-negative breast cancer.
J Surg Res
; 220: 46-51, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29180210
14.
Human α-amino-ß-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD): a structural and mechanistic unveiling.
Proteins
; 83(1): 178-87, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25392945
15.
The oxygenating constituent of 3,6-diketocamphane monooxygenase from the CAM plasmid of Pseudomonas putida: the first crystal structure of a type II Baeyer-Villiger monooxygenase.
Acta Crystallogr D Biol Crystallogr
; 71(Pt 11): 2344-53, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26527149
16.
Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancer.
Breast Cancer Res Treat
; 145(1): 155-64, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24692082
17.
Substrate profiling of cyclohexylamine oxidase and its mutants reveals new biocatalytic potential in deracemization of racemic amines.
Appl Microbiol Biotechnol
; 98(4): 1681-9, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23793344
18.
Isolation and characterization of marine nonylphenol-degrading bacteria and description of Pseudomaricurvus alkylphenolicus gen. nov., sp. nov.
Curr Microbiol
; 68(2): 167-73, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24051555
19.
Characterization of CpdC, a large-ring lactone-hydrolyzing enzyme from Pseudomonas sp. strain HI-70, and its use as a fusion tag facilitating overproduction of proteins in Escherichia coli.
Appl Environ Microbiol
; 79(22): 7091-100, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24038681
20.
Camphor pathway redux: functional recombinant expression of 2,5- and 3,6-diketocamphane monooxygenases of Pseudomonas putida ATCC 17453 with their cognate flavin reductase catalyzing Baeyer-Villiger reactions.
Appl Environ Microbiol
; 79(10): 3282-93, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23524667